Business, Policy & Funding

Exai Bio, Quantum Leap Healthcare Collaborative Expand Participation in RNA Liquid Biopsy Trial

Merck Nabs Full FDA Approval for Keytruda in MSI-High, dMMR Solid Tumors

European Commission Approves Libtayo in PD-L1-Positive Non-Small Cell Lung Cancer

NICE Backs Merck's Keytruda for PD-L1-Expressing Cervical Cancer

Genialis Closes $13M Series A Funding Round

Incyte's Pemazyre Approved in Japan for FGFR1-Positive Rare Blood Cancers

Novartis Seeks Adjuvant Kisqali Approval After Phase III Readout in Early-Stage Breast Cancer

Concentra Biosciences to Acquire Jounce Therapeutics

Flare Therapeutics Raises $123M in Oversubscribed Series B Funding Round

William Blair Initiates Coverage of MDxHealth With Outperform Rating

White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development

In Brief This Week: Fore Biotherapeutics, RayzeBio, Gilead Sciences, Atossa Therapeutics

Massive Bio, NeoGenomics Collaborate on AI-Driven Oncology Clinical Trial Matching

Previse Launches Esophageal Cancer Risk Test, Raises $3M to Support Commercial Expansion

Guardant Health, Ohio State University Partner on Blood-Based Colon Cancer Screening Study

Novartis Nets FDA Approval for Tafinlar-Mekinist in Pediatric Low-Grade Glioma

In Brief This Week: Ellipses Pharma, Perspective Therapeutics, Exscientia, Deciphera Pharmaceuticals